Adenoid cystic carcinoma of the breast
case report
Keywords:
adenoid cystic carcinoma, breast neoplasms, triple-negative breast neoplasmsAbstract
Adenoid cystic carcinoma (AdCC) of the breast is an uncommon invasive lobular neoplasm whose morphology is similar to the homonymous tumor of salivary glands and with a peculiar behavior toward the “triple-negative” (TN) profile. Tumors belonging to this family do not immunohistochemically express three of the main prognostic biomarkers and tend to show a more aggressive behavior. However, this rare histological pattern of breast cancer is generally associated with good prognosis. In this study, the authors describe the case of a 49-year-old woman diagnosed with this rare malignant tumor and who underwent breast-conserving surgery. Recent studies have aimed to understand the genes, genetic alterations, and etiological aspects related to the still obscure etiopathogenesis of AdCC. Thus, morphological and molecular aspects relevant to AdCC and reported in the literature will be discussed.
Downloads
References
Instituto Nacional de Câncer José Alencar Gomes da Silva. A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação [Internet]. Brazil: Instituto Nacional de Câncer José Alencar Gomes da Silva; 2019 [accessed on November 25, 2020]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/a_situacao_ca_mama_brasil_2019.pdf
World Health Organization (WHO). WHO Classification of Tumours Editorial Board. Breast tumours [Internet]. 5ª ed. Lyon: International Agency for Research on Cancer; 2019 [accessed on November 24, 2020]. v. 2. Available from: https://publications.iarc.fr/581
Brasil. Ministério da Saúde. Sistema de Informação do Colo do Útero. Sistema de Informação do câncer de mama. Datasus [Internet]. Ministério da Saúde [accessed on November 24, 2020]. Available from: http://w3.datasus.gov.br/siscam/index. php?area=0402
Vranic S, Bender R, Palazzo J, Gatalica Z. A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics. Hum Pathol. 2013;44(3):301-9. https://doi.org/10.1016/j. humpath.2012.01.002
Goldblum JR, Lamps LW, McKenney JK, Myers JL. Rosai and Ackerman’s Surgical Pathology. 9ª ed. Philadelphia: Elsevier; 2004. v. 2. 1828 p.
Epstein J, Simpson J, Sanders M. Differential Diagnosis in Surgical Pathology: Breast. Philadelphia: Wolters Kluwer Health; 2016.
Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Arch Pathol Lab Med. 2018;142(11):1364-82. https://doi.org/10.5858/arpa.2018-0902-sa
Ghabach B, Anderson WF, Curtis RE, Huycke MM, Lavigne JA, Dores GM. Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study. Breast Cancer Res. 2010;12:R54. https://doi.org/10.1186/bcr2613
Cambruzzi E, Pêgas KL, Zettler CG, Zettler EW. Carcinoma adenoide cístico de mama: relato de caso de uma rara neoplasia. Rev AMRIGS. 2012;56(2):161-3.
Romeira D, Cardoso D, Miranda H, Martins A. Adenoid cystic carcinoma: triple negative breast cancer with good prognosis. BMJ Case Rep. 2016;2016:bcr2015213704. https://doi.org/10.1136/bcr-2015-213704
Ferlay J, Colombet M, Soerjomataram I, Matheus C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: Globocan sources and methods. Int J Cancer. 2019;144(8):1941-53. https://doi.org/10.1002/ijc.31937
Righi A, Lenzi M, Morandi L, Flamminio F, De Biase D, Farnedi A, et al. Adenoid cystic carcinoma of the breast associated with invasive duct carcinoma: a case report. Int J Surg Pathol. 2011;19(2):230-4. https://doi.org/10.1177/1066896909332321
Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, et al. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update. J Clin Oncol. 2020;38(12):1346-66. https://doi.org/10.1200/JCO.19.02309
Stoeck A, Lejnine S, Truong A, Pan L, Wang H, Zang C, et al. Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma. Cancer Discov. 2014;4(10):1154-67. https://doi.org/10.1158/2159-8290.CD-13-0830
Yin L, Duan JJ, Bian XW, Yu SC. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22(1):61. https://doi.org/10.1186/s13058-020-01296-5
Thompson K, Grabowski J, Saltzstein SL, Sadler GR, Blair SL. Adenoid cystic breast carcinoma: is axillary staging necessary in all cases? Results from the California Cancer Registry. Breast J. 2011;17(5):485-9. https://doi.org/10.1111/j.1524-4741.2011.01117.x
Veeraraghavan J, De Angelis C, Reis-Filho JS, Pascual T, Prat A, Rimawi MF, et al. De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance. Breast. 2017;34(Suppl. 1):S19-S26. https://doi.org/10.1016/j.breast.2017.06.022
Millar BM, Kerba M, Youngson B, Lockwood GA, Liu F. The potential role of breast conservation surgery and adjuvant breast radiation for adenoid cystic carcinoma of the breast. Breast Cancer Res Treat. 2004;87:225-32. https://doi.org/10.1007/s10549-004-8693-z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Matheus Lavigne Marinho, Alexandre Tafuri, Carlos Alberto da Silva Ramos, Antônio Alexandre Lisbôa Ladeia, Luciana de Carvalho Azevedo
This work is licensed under a Creative Commons Attribution 4.0 International License.
